Medical Tourism in Lebanon 2026: The Complete Market Guide

TL;DR: Key Takeaways

• Lebanon is a genuinely different kind of market from every other destination covered in this guide series. It combines a historically strong tertiary medical reputation — anchored by the American University of Beirut Medical Center (AUBMC) — with an unresolved, multi-year national economic and healthcare crisis that any credible market analysis has to address directly, not minimize.

• No independent, audited market-size figure exists for Lebanese medical tourism specifically. The most-cited historical figure is roughly 5,000 medical tourists in 2018, predating the 2019 currency collapse, the 2020 Beirut port explosion, and the September–November 2024 conflict with Israel — meaning even that figure is a pre-crisis baseline, not a current estimate.

• Lebanon's currency collapsed by more than 90% against the US dollar after 2019, and its healthcare system has been described in peer-reviewed literature as facing possible collapse, driven by a severe and ongoing physician and nurse brain drain, foreign-currency shortages for medical supplies, and — as of late 2024 — direct conflict damage to healthcare infrastructure, with the World Health Organization confirming 23 attacks on healthcare facilities between September and December 2024 alone.

• Despite this, Lebanon retains genuine, internationally recognized clinical strength in cardiology, oncology, fertility medicine (IVF and egg freezing), and cosmetic and plastic surgery, delivered largely in US dollars by physicians frequently trained in Europe or North America.

• A coordinated 2026 push to rebuild the sector is underway, including a National Conference for the Development of the Lebanese Medical Tourism Strategy hosted by Holy Spirit University of Kaslik (USEK), signaling early-stage coordination between academia, industry, and policymakers rather than an established, mature promotion apparatus.

• The Lebanese diaspora — estimated at several times the size of Lebanon's resident population — is the single most distinctive demand driver in this market, and any credible facilitation strategy for Lebanon needs to be built around diaspora medical travel first, not generic international patient acquisition.

What Is Medical Tourism in Lebanon?

Medical tourism in Lebanon is the practice of international patients — and, distinctively, members of the global Lebanese diaspora — travelling to Lebanon specifically to receive medical, dental, cosmetic, or fertility treatment. Among every market covered in this guide series so far — Australia, Germany, the United Kingdom, Dubai, and Turkey — Lebanon is the first where a responsible market report cannot lead with growth statistics and a promotional tone, because the underlying story is genuinely more complicated than that framing would allow.

Lebanon entered the 2010s with a reputation, still cited today, as a "prominent tertiary medical hub in the Middle East," a secondary and tertiary care-focused system that regularly drew patients from across the Arab world for specialized treatment unavailable in their home countries. That reputation was built on real institutional strength: the American University of Beirut Medical Center, physicians trained at leading European and North American institutions, and a private hospital sector operating largely in US dollars with Western-style infrastructure.

Since 2019, that same system has been operating inside one of the most severe compounded national crises documented in recent healthcare policy literature: a currency collapse that wiped out the value of local wages and savings, a global pandemic, the catastrophic Beirut port explosion in August 2020, and — in the autumn of 2024 — direct armed conflict that damaged healthcare infrastructure and killed health workers. For agencies, facilitators, and hospital international patient departments (IPDs) considering this market, both of these realities are true simultaneously, and a credible strategy has to be built with that duality in mind from the outset, not around a choice between an optimistic or a cautionary narrative.

What Is the Current State of Lebanon's Healthcare System?

This section comes before the market-sizing and opportunity discussion deliberately, because in Lebanon's case, the underlying system condition is a precondition for understanding everything that follows — unlike the other five markets in this series, where system stability could reasonably be assumed as a backdrop.

The 2019 Economic Collapse and Its Healthcare Impact

Lebanon has been grappling with a severe financial crisis since 2019, compounded by social unrest, the devastating Beirut port explosion in 2020, and the coronavirus pandemic, according to peer-reviewed health economics research. The Lebanese pound lost more than 90% of its value against the US dollar following the onset of the crisis, wiping out the real value of medical staff salaries and hospital operating budgets alike. Hospitals in Lebanon have struggled financially due to difficulties accessing foreign currency to purchase supplies and equipment from abroad, an inability to collect full payment from domestic insurance companies operating in devalued local currency, and a broader decrease in government health funding — a combination researchers have explicitly described as threatening the health system's possible collapse.

The Physician and Nurse Brain Drain

The currency collapse triggered a well-documented mass emigration of healthcare workers. Research into the exodus of Lebanese doctors during this period found that the severe devaluation of the national currency led to a sharp decline in the real value of medical wages, which, combined with a broader lack of incentives to retain skilled staff, resulted in a mass departure of experienced doctors and nurses from the country. This brain drain is a critical fact for any agency evaluating Lebanon's medical tourism potential: the same historic reputation for internationally trained physicians that built Lebanon's tertiary care standing is, at the institutional level, under sustained strain from the departure of exactly the specialists that reputation depends on.

The September–November 2024 Conflict and Its Direct Impact on Healthcare Infrastructure

Beyond the economic crisis, Lebanon's healthcare system sustained direct conflict damage in late 2024. Following the outbreak of armed conflict with Israel on 17 September 2024, the World Health Organization confirmed 23 attacks on healthcare facilities in Lebanon, resulting in the deaths of 72 health workers and patients and injuring a further 43. Intense bombardment and growing insecurity forced 100 of Lebanon's 207 primary healthcare centres to close, particularly in the south of the country, and multiple hospitals closed entirely or were evacuated due to proximity to active bombardment. This is materially more severe direct infrastructure damage than any other market covered in this guide series has experienced, and it occurred within the same broad period this guide series otherwise covers.

It is important for agencies to understand the geographic pattern of this impact rather than treating it as a uniform, nationwide disruption. The primary healthcare centre closures and facility attacks documented by the WHO were concentrated specifically in southern Lebanon and other areas closer to the conflict's active front lines, rather than distributed evenly across the entire country. Beirut's core hospital district — home to AUBMC, Clemenceau, Rizk, and the other institutions most central to the country's medical tourism sector — continued operating throughout this period, though under the broader strain, staffing pressure, and general uncertainty that any healthcare system operates under during an active national conflict. This distinction matters for accurate risk communication: the damage was severe and real, but it was not uniformly distributed across every part of the country or every hospital relevant to international patient care.

What Has Not Collapsed

Against this backdrop, it is equally important — and equally factual — to note what has continued operating. Lebanon's major private tertiary hospitals, concentrated in and around Beirut, have continued to function throughout this period, treating both Lebanese patients and, per industry sources, a continuing flow of international and diaspora patients specifically for cosmetic, fertility, and specialized care. Academic and industry sources published as recently as 2025 and early 2026 continue to describe Lebanon's private clinics as MOH-licensed, some holding international accreditations, staffed by multilingual, often internationally trained physicians — the institutional core of Lebanon's medical tourism reputation has proven more resilient than the broader public health system, though it operates under real and ongoing strain.

For an agency or hospital IPD trying to translate this into a practical operating principle: Lebanon's medical tourism sector should be understood as running through a small number of resilient private institutions that have continued operating despite, rather than because of, the surrounding national system's condition. This is structurally different from every other market in this guide series, where the destination country's healthcare system broadly underpins the medical tourism sector. In Lebanon's case, a small cluster of well-run private institutions is functioning as an island of continuity within a national system under sustained strain — a distinction worth making explicitly to any patient, investor, or partner trying to understand how the sector can simultaneously host genuine clinical excellence and a country-wide healthcare crisis.

Is There a Reliable Market Size Figure for Medical Tourism in Lebanon?

Unlike every other market covered in this guide series, there is no current, dedicated commercial market-size report for Lebanese medical tourism specifically, and agencies should treat this absence itself as meaningful information, not simply a data gap to work around.

The most frequently cited figure in industry compilations is approximately 5,000 medical tourists in Lebanon in 2018, drawn to cosmetic surgery, dental care, and oncology — a figure that predates the 2019 currency collapse, the 2020 port explosion, the pandemic, and the 2024 conflict entirely. No comparably sourced, updated figure for 2024, 2025, or 2026 patient volume appears in the available research, in sharp contrast to Turkey's consistently cited 1.5–2 million 2024 figure, Dubai's officially published 691,000 2023 figure, or even Germany's more loosely estimated 250,000 blended figure.

Lebanon does appear as a named growth market within broader regional analysis: countries such as Lebanon, the UAE, Egypt, and South Africa are becoming increasingly recognized within the Middle East and Africa region specifically for fertility clinics offering IVF, ICSI, donor services, egg freezing, and related reproductive services, reflecting genuine sector-level strength even in the absence of a dedicated national patient-volume figure. Beyond this fertility-specific mention, Lebanon is not separately broken out in any of the major global or regional medical tourism market reports reviewed for this guide, unlike Turkey, the UAE, or the other destinations covered so far.

What this means practically: any agency, investor, or hospital IPD asked to cite "the size of the Lebanese medical tourism market" should be direct that no current, credible figure exists, rather than repeating the outdated 2018 estimate as though it reflects the market today. This is a meaningfully different starting point from every other market in this series, and it should shape expectations about the maturity of available planning data from the outset.

Is Lebanon an Inbound or Outbound Medical Tourism Market?

Lebanon is best understood as an inbound-oriented market with a genuinely distinctive demand structure built around diaspora medical travel, regional Arab patients, and — most recently — a documented outbound dimension driven by the same healthcare system pressures described above.

The Diaspora Dimension

This is the single most distinctive feature of Lebanon's medical tourism structure relative to every other market in this guide series. The Lebanese diaspora is widely estimated to be several times larger than Lebanon's resident population, spread across the Americas, Europe, Africa, Australia, and the wider Gulf region, with deep, ongoing family, property, and financial ties to Lebanon that persist across generations. Diaspora medical travel — Lebanese-heritage patients returning to Lebanon for treatment, often to be near family, and often specifically for procedures like fertility treatment, cosmetic surgery, or specialist consultations with physicians recommended through family networks — represents a fundamentally different demand pattern from the cold-outreach international patient acquisition that dominates marketing strategy in Turkey, Dubai, or Germany. Trust in this segment is inherited through family and community relationships rather than built through paid marketing, which has direct implications for how an agency should realistically expect to acquire patients in this specific market.

Major diaspora population centres relevant to this demand pattern include large, well-established Lebanese communities in Brazil and the wider Latin American region, francophone West Africa, France and the wider European Union, North America — particularly the United States, Canada, and Australia — and significant, longer-established communities across the Gulf states. Each of these populations maintains a different relationship with Lebanon depending on the generation and era of emigration involved: some diaspora members travel to Lebanon regularly for family visits and would naturally consider treatment during an already-planned trip, while others, particularly later-generation diaspora with looser day-to-day ties, may need considerably more practical orientation and reassurance before considering medical travel to a country they may never have visited themselves. A facilitation business built around this audience needs to recognise these are not one homogeneous segment, but a spectrum of diaspora proximity to Lebanon that materially changes what kind of marketing, reassurance, and logistical support each sub-segment actually needs.

Regional Arab Patients

Lebanon's geographic and cultural position within the Arab world, combined with visa-free access for citizens of Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, the United Arab Emirates, and Jordan, continues to support a flow of regional patients, particularly for cosmetic and fertility procedures, consistent with Lebanon's long-standing positioning as a lower-cost, culturally familiar alternative to treatment in Europe for Gulf Arab patients specifically. This regional patient base overlaps meaningfully with Dubai's own inbound market described in this series' Dubai guide, and agencies operating across both destinations should expect some degree of genuine competitive overlap for this specific patient segment, with Lebanon's comparative advantage resting on lower absolute cost and, for some patients, deeper pre-existing cultural and business ties to Beirut specifically, while Dubai's advantage rests on its more developed verification infrastructure and broader accreditation base.

The Emerging Outbound Dimension

Distinct from every other inbound-dominant market covered in this series except in degree, Lebanon's own healthcare crisis has generated a documented outbound dimension of its own: Lebanese patients with the financial means to do so increasingly seek treatment abroad — in the Gulf, in Europe, or through diaspora family networks — for conditions that Lebanon's strained public and, in some cases, private system can no longer reliably treat, particularly given documented cardiovascular drug shortages and broader medicine supply disruption. This is a fundamentally different outbound dynamic from Australia's or the UK's price-driven outbound flow: it is driven by domestic system capacity and supply reliability rather than by cost comparison against a well-functioning home system. This outbound flow is, notably, the reverse of the diaspora-driven inbound pattern described above — the same global Lebanese community that brings patients home for treatment when Lebanon's system can meet their needs also represents a support network Lebanese residents themselves increasingly draw on when it cannot.

Why Do Patients Choose Lebanon for Treatment?

Despite the system-level challenges documented above, patients continue choosing Lebanon for a specific, recurring set of reasons that agencies should understand precisely rather than substitute with generic destination marketing claims.

Historic institutional reputation, anchored overwhelmingly by AUBMC. The American University of Beirut Medical Center is consistently described as Lebanon's premier academic medical centre, a teaching hospital affiliated with AUB's Faculty of Medicine, particularly renowned for its cancer centre — the Naef K. Basile Cancer Institute — cardiovascular services, and organ transplantation programmes, and functioning as a regional referral centre for complex cases offering advanced treatments including robotic surgery and stem cell transplantation. Other private tertiary institutions, including Clemenceau Medical Center — affiliated with Johns Hopkins Medicine International — and Rizk Hospital, are similarly cited for cardiovascular surgery, oncology, neurosurgery, and cosmetic procedures, and Clemenceau specifically is noted for drawing patients from various Arab nations for complex procedures.

This institutional reputation predates the current crisis period by decades, and it is worth understanding why it has proven more durable than Lebanon's broader public health infrastructure. AUBMC and Lebanon's other leading private tertiary hospitals have historically operated with a degree of financial and administrative independence from the Lebanese state, funded substantially through private patient revenue, philanthropic support, and, in AUBMC's case, its affiliation with the American University of Beirut's broader institutional and international academic network — structural features that have provided a meaningful degree of insulation from the public-sector funding collapse documented earlier in this guide, even as these institutions have not been immune to the broader currency and brain-drain pressures affecting the country as a whole.

Fertility and reproductive medicine strength. IVF, egg freezing, and broader reproductive endocrinology represent one of the most consistently cited areas of genuine Lebanese clinical strength, with AUBMC operating a dedicated Fertility Preservation Program and Division of Reproductive Endocrinology and Infertility, and Rizk Hospital and Saint Joseph's University Hospital also specifically noted for fertility treatment alongside cardiovascular and oncology care respectively. This specific strength is also independently corroborated outside Lebanon-specific promotional sources: regional Middle East and Africa market analysis explicitly names Lebanon, alongside the UAE, Egypt, and South Africa, as a country becoming increasingly recognized for its fertility clinic capability — a rare instance in this guide's research where Lebanon's clinical reputation is confirmed by a source with no direct commercial interest in promoting Lebanon specifically.

Cost, now denominated almost entirely in the practical currency reality of a dollarized private healthcare sector. Private treatment in Lebanon is typically priced and paid in US dollars given the collapse of the Lebanese pound, and industry sources describe savings of up to 70% relative to Western pricing for comparable cosmetic and dental procedures — though, as throughout this guide series, this figure should be treated as an industry estimate rather than an audited benchmark, and patients should be advised to obtain a specific, itemized quote rather than relying on a general percentage claim. This dollarization is, in a narrow sense, one of the few structural silver linings of Lebanon's currency collapse for international patients specifically: a private sector forced to price in a stable foreign currency for its own survival has, as a side effect, produced pricing that is genuinely predictable and comparable for a dollar- or euro-earning international patient, even as the same currency dynamics have devastated domestic Lebanese patients' purchasing power for the identical services.

Language and cultural familiarity, particularly for diaspora and regional Arab patients: Lebanese medical staff are widely described as multilingual across Arabic, English, and French, and hospitals are noted for accommodating cultural needs including halal meals, prayer spaces, and gender-specific care where relevant. This trilingual capability is itself a legacy of Lebanon's particular colonial and educational history, and it remains one of the country's most consistently cited soft advantages relative to destinations where English alone is the standard second language of clinical staff.

Physical recovery environment. Lebanon's combination of Mediterranean coastline and mountain landscape within a short drive of Beirut's hospital district is repeatedly cited in patient-facing marketing as a distinctive recovery setting, particularly for cosmetic surgery patients — a positioning similar in spirit to Turkey's tourism-integrated treatment packages, though at meaningfully smaller scale and, as discussed later in this guide, one that should be marketed with more conservative, security-aware messaging than Turkey's more established tourism-integrated model currently requires.

How Do International Patients Access Healthcare in Lebanon?

Lebanon's visa system is more fragmented by nationality than any other market covered in this guide series, and agencies need nationality-specific fluency rather than a single general process to advise patients accurately.

Visa Requirements by Nationality

Lebanon operates a genuinely tiered visa system. Citizens of Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the United Arab Emirates can travel to Lebanon without any visa at all, and Jordanian citizens receive a free visa on arrival valid for up to three months — reflecting Lebanon's positioning toward its most geographically and culturally proximate Gulf and regional source markets. Citizens of a substantially wider group, reported at over 70 to more than 80 countries depending on the source, including the United States, the United Kingdom, and Canada, can obtain a visa on arrival at Beirut–Rafic Hariri International Airport, typically issued initially for one month and extendable up to three months. Citizens of certain other countries, including some African and Asian nations, face a conditional visa-on-arrival process requiring proof of sufficient funds, or must apply in advance through a Lebanese embassy or consulate, with processing potentially taking one to two weeks or, in some cases with additional security clearance requirements, considerably longer.

For patients travelling specifically for medical treatment and applying through a Lebanese embassy in advance rather than relying on visa-on-arrival, a document proving the medical treatment to be received in Lebanon is a standard supporting document, similar in principle to the treatment-confirmation letters required in Australia, Germany, the UK, and Dubai, though Lebanon's process is less formally codified as a dedicated "medical visa" category than the equivalent frameworks in those other markets.

One nationality-based restriction applies universally and is worth stating plainly: entry to Lebanon is refused to holders of an Israeli passport, or to any traveller whose passport bears an Israeli stamp or visa, regardless of the purpose of travel, including medical treatment. This is a hard, non-negotiable entry restriction that agencies serving any patient population needs to communicate clearly and early, since it affects trip planning in ways with no equivalent in any other market in this series.

Payment and Insurance

As throughout this guide series, genuine medical tourists in Lebanon are self-pay patients, and this reality is reinforced by Lebanon's broader currency situation: even in emergencies, Lebanese hospitals generally require proof that a patient is able to cover treatment costs before proceeding, given the currency and liquidity pressures the sector as a whole continues to operate under. Travel health insurance is strongly recommended, though not legally mandatory for tourist entry, and should specifically include medical evacuation coverage — a more pointed recommendation in Lebanon's case than in the other markets covered in this series, given the documented healthcare infrastructure strain and the possibility of rapidly changing security conditions.

What Regulatory Framework Governs Medical Tourism in Lebanon?

Lebanon's regulatory environment for medical tourism specifically is considerably less developed and less centrally coordinated than the frameworks documented in Turkey, Dubai, Australia, Germany, or the UK, reflecting the sector's early-stage, recovery-oriented status rather than the mature, purpose-built systems seen elsewhere in this series.

Ministry of Public Health Licensing

Lebanon's Ministry of Public Health (MOPH) is the primary regulator responsible for licensing hospitals and healthcare facilities, and industry sources describe top-tier Lebanese clinics as MOH-licensed, with some holding additional international accreditations layered on top of domestic licensing — though, unlike Turkey's newly mandatory TUSKA framework or Dubai's DHA/DHCC dual-regulator system, there is no evidence in available sources of a dedicated, medical-tourism-specific accreditation or portal-registration requirement comparable to Turkey's HealthTürkiye system.

The 2026 National Medical Tourism Strategy Initiative

The clearest sign of coordinated regulatory and strategic development in this market is very recent. Holy Spirit University of Kaslik (USEK) hosted a National Conference for the Development of the Lebanese Medical Tourism Strategy, explicitly described as signaling intensified coordination between academia, industry stakeholders, and policymakers to position Lebanon as a strategic destination for healthcare travellers, with officials and sector analysts specifically emphasizing the importance of strengthening digital readiness, marketing infrastructure, and international visibility. This is a genuinely early-stage development — an academic-industry conference laying groundwork for a national strategy — rather than an implemented regulatory framework, and it should be read as exactly that: a signal of intent and momentum, not evidence of an established coordinated system comparable to Turkey's USHAŞ or Dubai's DHA.

What This Means for Agencies

For agencies and facilitators, this less-developed regulatory environment cuts in two directions. On one hand, there is currently no equivalent to Turkey's mandatory HealthTürkiye registration or complication insurance requirement, meaning the compliance barrier to entry is lower than in several other markets in this series. On the other hand, this also means there is currently less formal, government-backed verification infrastructure available to confirm a given provider's standing — placing more of the due-diligence burden on the agency itself, through direct verification of MOPH licensing and any international accreditation a specific hospital holds, rather than relying on a centralized national verification portal of the kind increasingly standard elsewhere in this guide series.

What Are the Biggest Opportunities for Entrepreneurs in Medical Tourism in Lebanon in 2026?

Given Lebanon's distinctive structure — genuine clinical strength inside a strained system, a globally significant diaspora, and an early-stage national strategy push — the clearest opportunities in 2026 differ meaningfully from the opportunity sets identified elsewhere in this guide series.

1. Diaspora-Specific Facilitation and Concierge Services

Given that diaspora medical travel operates on inherited trust through family and community networks rather than conventional marketing acquisition, there is a clear opportunity for facilitation services specifically designed around this population's distinctive needs — coordinating treatment with family visits, managing logistics for diaspora patients who may not have visited Lebanon in years or decades, and bridging the information gap between diaspora patients' adopted-country healthcare expectations and Lebanon's current system realities.

2. Independent Provider Verification, Given the Less-Developed National Framework

Because Lebanon currently lacks a centralized verification portal comparable to Turkey's HealthTürkiye system, there is a genuine, currently unmet opportunity for independent verification services confirming MOPH licensing status, international accreditation, and continuity of operations for specific Lebanese providers — directly addressing the due-diligence burden the less-developed regulatory environment currently places on individual agencies and patients.

3. Fertility and Reproductive Medicine Concierge Services

Given Lebanon's clearly documented, internationally recognized strength in IVF and reproductive medicine specifically, and given this category's explicit mention in regional Middle East and Africa market analysis as a growth area, there is a clear opportunity for specialized fertility-focused facilitation, mirroring the opportunity identified for Dubai's fertility sector in this series but built around Lebanon's comparatively lower cost base and its specific institutional strength at AUBMC and allied hospitals.

4. Contributing to the National Medical Tourism Strategy Process

Given that Lebanon's coordinated national strategy effort is genuinely early-stage, agencies, technology providers, and industry consultants who engage directly with the USEK-hosted strategy process and its academic and policy stakeholders have a meaningful opportunity to help shape the digital readiness, marketing infrastructure, and international visibility priorities this initiative has explicitly identified as its focus areas — a rare opportunity, relative to the more mature markets in this series, to influence sector-level infrastructure decisions at a formative stage rather than adapting to an already-established system.

This kind of early-stage engagement carries a different risk-and-reward profile than the more straightforward market-entry opportunities documented elsewhere in this guide series. There is no guarantee the USEK-led process will produce the kind of comprehensive, government-backed framework Turkey has built through USHAŞ and HealthTürkiye, and an organisation investing time in this process should treat it as a genuine, longer-horizon relationship-building and sector-shaping opportunity rather than a near-term commercial pipeline. For a technology provider or CRM vendor specifically, however, being present and credible during this formative period — rather than arriving only once a formal national framework already exists, as would now be the case entering Turkey or Dubai — represents a genuinely distinctive positioning opportunity unavailable in any of the four other markets covered in this guide series.

5. Post-Treatment Continuity Services for Diaspora Patients Returning to Their Adopted Countries

Because diaspora patients frequently return to a home country with a very different, often more stable healthcare system after treatment in Lebanon, there is a clear opportunity for structured continuity services — documentation transfer, coordination with a specialist in the patient's country of residence, and telehealth follow-up — addressing a genuine care-coordination gap distinct from, though structurally similar to, the aftercare gaps documented throughout the Australia, Germany, and UK guides in this series.

6. Purpose-Built CRM and Diaspora-Aware Case-Management Technology

Given Lebanon's genuinely distinctive diaspora-driven demand structure, its currently limited national verification infrastructure, and its multi-currency, multi-country patient base spanning the Americas, Europe, Africa, Australia, and the Gulf, a vertical CRM built specifically to track diaspora patient relationships, document independent provider verification status, and manage multi-country, multi-timezone case coordination represents infrastructure this market currently lacks almost entirely — arguably an even clearer technology gap than in the more mature markets covered elsewhere in this series, precisely because Lebanon's sector-wide digital readiness has been explicitly identified as underdeveloped by the market's own emerging national strategy process.

Which Lebanese Cities and Hospitals Lead in Medical Tourism?

Lebanon's medical tourism infrastructure is heavily concentrated in and around Beirut, with a small number of secondary hubs, reflecting both the country's small geographic size and the concentration of tertiary specialist capacity in the capital.

Beirut is overwhelmingly the centre of the sector, home to the majority of the hospitals most frequently cited in medical tourism coverage. Beyond AUBMC, Clemenceau Medical Center, affiliated with Johns Hopkins Medicine International, is specifically noted for adopting the latest medical technologies and drawing patients from various Arab nations for complex procedures, positioning it as one of Lebanon's most internationally oriented private hospitals. Rizk Hospital is known specifically for cardiovascular surgery, fertility treatment, and plastic surgery — a combination of specialties that maps closely onto the treatment categories most cited throughout this guide as Lebanon's core areas of strength. Saint George Hospital University Medical Center, in Beirut's Ashrafieh district, and Lebanese American University Medical Center (LAUMC) round out the most frequently cited Beirut institutions, the latter particularly noted for emergency care and internal medicine capacity. This concentration of six or more internationally oriented tertiary institutions within a single metropolitan area, comparable in density if not in absolute scale to Istanbul's own hospital cluster, is a genuine structural asset that Lebanon's broader system challenges have not eliminated.

Jounieh, a coastal city north of Beirut, and Zahle, in the Bekaa Valley, are specifically identified alongside Beirut as key medical hubs in industry destination profiles, reflecting some degree of geographic distribution beyond the capital, though at considerably smaller scale than Beirut's concentration of tertiary specialist capacity.

Mount Lebanon Hospital University Medical Center, in Hazmieh just outside central Beirut, is specifically noted for cutting-edge cancer treatment technology and for welcoming a meaningful number of patients from abroad, while Byblos Hospital, further north along the coast, is noted for cardiology and obstetric and gynaecological services — together illustrating a pattern where individual hospitals beyond the AUBMC-Clemenceau-Rizk core have developed narrower, specialty-specific reputations rather than each competing as a full-service tertiary centre. This pattern of specialty concentration among Lebanon's secondary hospital tier mirrors, at smaller scale, the city-specific specialization documented for Turkey's Bursa and Anadolu Medical Centre elsewhere in this guide series.

For agencies, this concentration has a direct practical implication similar to the one noted in this series' Dubai guide: a facilitation business does not need a genuinely national footprint to serve the substantial majority of Lebanon's medical tourism capacity — proximity to and strong working relationships with Beirut's core hospital cluster covers most of the addressable opportunity, with Jounieh and Zahle representing smaller, more specialized secondary relationships worth developing over time rather than a primary focus for a new entrant.

How Do You Start a Medical Tourism Facilitation Business Targeting Lebanon?

Given Lebanon's distinctive diaspora-driven demand structure, its currently underdeveloped national verification infrastructure, and the genuine dual reality of clinical strength inside a strained system, entrepreneurs entering this market in 2026 need a meaningfully different build sequence than in the more mature markets covered elsewhere in this guide series.

Step 1: Decide Whether You Are Building a Diaspora-First or a Regional-Patient-First Business

Because diaspora medical travel and regional Arab patient acquisition operate on fundamentally different trust and marketing mechanics — inherited family and community trust versus more conventional destination marketing — a new entrant should choose one as a primary initial focus rather than attempting to serve both audiences with the same content and acquisition strategy from day one. A diaspora-first business will likely need to invest early in community relationships, diaspora media, and religious or cultural organization partnerships; a regional-patient-first business will look structurally closer to the marketing approaches documented for Dubai and Turkey elsewhere in this series.

Step 2: Build Direct, Independently Verified Provider Relationships

Because Lebanon currently lacks a centralized national verification portal, a new entrant's provider relationships need to be built through direct verification — confirming current MOPH licensing status, any international accreditation actually held (rather than historically claimed), and, given the documented brain drain, the current availability and continuity of specific named specialists a patient would actually be treated by, rather than relying on a hospital's general historic reputation alone.

Step 3: Build Active Security and Travel-Advisory Monitoring Into Your Standing Operating Process

Unlike every other market in this guide series, a Lebanon-facing facilitation business needs an ongoing, standing process for monitoring official government travel advisories and current security conditions, with clear internal protocols for how the business communicates with, or pauses new bookings for, prospective patients during periods of elevated risk. This is not a one-time due-diligence step completed at business launch; it is an ongoing operational requirement specific to this market.

Step 4: Design Pricing and Payment Processes Around Lebanon's Dollarized, Cash-Preferential Reality

Given Lebanon's currency situation and the documented preference for US dollar transactions in the private healthcare sector, a facilitation business needs payment processes genuinely built around this reality — clear dollar-denominated quoting, and realistic guidance to patients about payment methods that will actually function reliably in Lebanon's current banking environment, rather than assuming the more standard international payment rails that work smoothly in Dubai, Turkey, or the European markets covered elsewhere in this series.

Step 5: Build Genuine Specialization Around Lebanon's Documented Strength Areas

Given how clearly cardiology, oncology, fertility medicine, and cosmetic surgery stand out as Lebanon's areas of genuine, internationally recognized strength, a new entrant is better served building deep specialization and provider relationships within one or two of these categories than attempting to offer generalist facilitation across every treatment type — mirroring the specialization advice given for Turkey's more saturated hair transplant sector, but here motivated by the need to build genuine clinical-quality confidence in a smaller, less centrally verified market rather than by competitive saturation.

Step 6: Instrument the Business for Diaspora Relationship Management, Not Just Transactional Patient Intake

Because diaspora medical travel is fundamentally relationship-driven rather than transactional, a Lebanon-facing facilitation business benefits from case-management infrastructure that tracks family and community referral relationships over time, not just individual patient bookings — a genuinely different data model from the source-attribution and quote-comparison tools that serve the more conventional patient-acquisition markets covered elsewhere in this series. A vertical CRM capable of tracking both diaspora relationship networks and independently verified provider credentials addresses two of the most distinctive infrastructure gaps in this specific market simultaneously.

What Marketing Approach Works for Medical Tourism Businesses Targeting Lebanon?

Given the genuine two-sided reality of Lebanon's current healthcare system, and given how central inherited trust is to this market's core diaspora audience, content marketing here needs a distinctly different approach from the compliance-first, regulation-anchored marketing strategies recommended for Turkey, Dubai, the UK, and Germany elsewhere in this series.

Practically, this means:

• Leading with honesty about current conditions rather than omitting them. Given the documented healthcare system strain and security considerations covered throughout this guide, content that acknowledges this context directly — and explains specifically how a given provider or facilitation service accounts for it — builds more durable trust with a well-informed diaspora and regional audience than content that presents Lebanon purely through its historic "Middle East's medical hub" framing without qualification.

• Building content around named institutions and named specialists rather than generic destination claims, given how concentrated Lebanon's genuine strength is around a small number of specific hospitals and physicians, and given the brain-drain-driven uncertainty about which specialists remain actively practising at any given institution at any given time.

• Producing content in Arabic, English, and French simultaneously as a baseline, reflecting the genuinely trilingual nature of both Lebanon's healthcare workforce and its diaspora and regional patient base, rather than treating this multilingual requirement as an optional expansion once a business has scaled.

• Engaging diaspora community channels directly — religious institutions, cultural associations, and diaspora media specific to major Lebanese diaspora population centres in North America, Europe, Australia, Africa, and the Gulf — rather than relying primarily on the paid search and social advertising channels that dominate patient acquisition strategy in the other markets covered in this series.

• Providing clear, current practical guidance on visa requirements by nationality, payment logistics in a dollarized cash-preferential economy, and recommended travel insurance including medical evacuation coverage, treating this as core content rather than a buried disclaimer.

For agencies and hospital IPDs building a content program around Lebanon specifically, the practical opportunity is distinctive relative to the rest of this guide series: because so little current, accurate, English-language content exists that honestly addresses both Lebanon's genuine clinical strength and its current system realities together, there is a meaningful first-mover advantage available to any agency or hospital willing to produce content with this level of honest, dual-sided specificity rather than defaulting to either uncritical destination marketing or an overly cautious risk-only framing.

What Payment Considerations Apply to Medical Tourism Patients in Lebanon?

Payment structure in Lebanon differs meaningfully from every other market in this guide series, shaped directly by the currency collapse documented earlier in this guide.

Cash and Dollar-Denominated Payment Remain Central

Given Lebanon's banking sector limitations since 2019 — including informal capital controls that have restricted depositor access to funds held in Lebanese banks — private healthcare providers commonly expect payment in US dollars, frequently in cash or through payment mechanisms that route around the constrained formal banking sector, rather than the standard international card and bank-transfer rails that function smoothly in the other markets covered in this series. Even in emergencies, Lebanese hospitals generally require proof that a patient is able to cover treatment costs before proceeding, reflecting the sector's own liquidity pressures rather than any lack of willingness to treat international patients.

No Reciprocal or Discounted Public-System Pathway

As throughout this guide series, genuine medical tourists in Lebanon are self-pay patients with no reciprocal public-system access framework comparable to Germany's EU Directive pathway or even the narrower RHCA-style arrangements documented in Australia and the UK — Lebanon's own public health system is under sufficient strain that it is not positioned as a realistic pathway for international patients in the way even a narrow reciprocal framework might otherwise provide.

Travel Insurance With Medical Evacuation Coverage

Given the security and infrastructure considerations documented throughout this guide, travel insurance specifically including medical evacuation coverage is a more consequential recommendation in Lebanon's case than in any other market in this series — not simply a prudent add-on, but a genuinely material consideration given the documented volatility of the country's recent security situation and the real possibility of hospital closures or access disruption during periods of instability.

What Does the Future Hold for Medical Tourism in Lebanon?

Unlike the more straightforwardly growth-oriented forecasts available for Turkey, Dubai, and the other markets in this guide series, Lebanon's near-term future is genuinely contingent on factors outside any individual agency's or hospital's control — currency and broader economic stabilization, continued security conditions, and the practical outcome of the sector's own early-stage strategic coordination efforts.

The clearest signal of forward momentum is the 2026 USEK-hosted National Conference for the Development of the Lebanese Medical Tourism Strategy, explicitly framed as intensified coordination between academia, industry stakeholders, and policymakers, with digital readiness, marketing infrastructure, and international visibility specifically identified as priority areas. Whether this initiative develops into an implemented, government-backed framework comparable to Turkey's HealthTürkiye system or Dubai's DHA-led coordination — or remains a more limited academic and industry coordination effort — will materially shape how investable and how professionally facilitatable this market becomes over the remainder of the decade.

Lebanon's underlying structural assets — AUBMC's continued academic and clinical standing, the country's uniquely large diaspora population, and its documented strength in fertility medicine specifically — remain genuine and durable regardless of near-term political and economic conditions, giving this market a plausible long-term recovery trajectory that is less purely speculative than it might first appear. At the same time, any responsible assessment of Lebanon's medical tourism future needs to hold this potential alongside the real, ongoing possibility of further economic or security disruption, rather than assuming a smooth, linear growth trajectory of the kind more reasonably projected for the other markets in this series.

Key Considerations for Ongoing Monitoring

What Are the Biggest Challenges Facing Medical Tourism in Lebanon?

Ongoing Healthcare System Strain and Brain Drain

The physician and nurse emigration documented throughout this guide directly affects the depth and continuity of specialist care available even at Lebanon's strongest private institutions, and agencies need to verify current staffing and specialist availability at any specific provider rather than relying on a hospital's historic reputation alone.

Currency and Broader Economic Instability

Even with private healthcare largely dollarized, Lebanon's broader economic instability affects hospital operating costs, staff retention, and supply chain reliability for medical equipment and pharmaceuticals sourced from abroad, creating background operational risk not present in the same form in any other market covered in this series.

Security and Political Risk

The September–November 2024 conflict and its direct impact on healthcare infrastructure represents a materially different risk category from any other market in this guide series, and any current, responsible facilitation strategy needs to include active monitoring of official government travel advisories and security conditions as a standing operational practice, not a one-time due-diligence step completed at business launch.

No Centralized National Verification Infrastructure

Unlike Turkey's HealthTürkiye portal, Dubai's DHA/DHCC system, or even the less formal but still government-anchored frameworks in Australia, Germany, and the UK, Lebanon currently has no dedicated national portal or accreditation system specific to medical tourism, placing a proportionally greater verification burden on individual agencies and patients.

Absence of Reliable, Current Market Data

As established earlier in this guide, no credible, current patient-volume or market-value figure exists for Lebanese medical tourism specifically, making investor conversations, business planning, and realistic demand forecasting considerably harder than in any other market covered in this series — agencies should be prepared to build bottom-up demand estimates from provider-level data and diaspora population research rather than relying on a top-down market-size figure that does not currently exist in credible form.

Managing Patient Expectations Around a Two-Sided Reality

Because Lebanon's genuine clinical strength and its genuine system-level strain both exist simultaneously, marketing that leans too heavily on either the historic "Middle East's medical hub" narrative or an overly cautious risk-only framing will misrepresent the market to prospective patients. Agencies need genuine skill in communicating both realities honestly and proportionately — a harder communication challenge than in any more straightforwardly positive or negative market covered in this series.

Lebanon vs Neighboring Medical Tourism Destinations

How Should Agencies Segment Their Marketing for the Lebanon Market?

Because Lebanon's demand structure is so distinctively diaspora-driven, and because the honest, two-sided reality of the market needs careful, accurate communication, segmentation here looks different from every other market in this guide series.

Diaspora-facing content should lead with the trust infrastructure this audience already has — family relationships, community physician recommendations, and continuity with Lebanon's historic reputation — rather than generic international-patient acquisition content built for a cold audience with no prior connection to the country. Content addressing practical logistics (current entry requirements, what to expect from Beirut's airport and hospital district, how the currency and payment system actually works day to day) tends to serve this audience better than aspirational destination marketing.

Regional Gulf Arab patient content should emphasize Lebanon's visa-free or visa-on-arrival access for GCC and Jordanian citizens specifically, alongside its cultural and linguistic familiarity, positioning Lebanon within the same general decision space as Dubai and Turkey for this audience rather than treating it as a wholly separate category.

Fertility-specific content, given this category's clearly documented clinical strength, should be built around AUBMC and allied institutions' specific reproductive medicine credentials, mirroring the fertility-focused segmentation approach recommended in this series' Dubai guide, adapted to Lebanon's dollarized cost base and diaspora-trust dynamics.

Across every segment, given the genuinely elevated and actively evolving security and system-stability considerations documented throughout this guide, content should include clear, current, and honestly stated practical guidance — insurance recommendations including medical evacuation coverage, and encouragement to check current travel advisories — rather than omitting this information in the interest of a more purely promotional tone.

Glossary of Key Terms

• Medical tourism — Travelling across an international border specifically to receive medical, dental, cosmetic, or fertility treatment.

• AUBMC — The American University of Beirut Medical Center, Lebanon's leading academic tertiary medical centre and the institutional anchor of the country's medical tourism reputation.

• MOPH — Lebanon's Ministry of Public Health, the primary regulator responsible for hospital and healthcare facility licensing.

• Diaspora medical tourism — Medical travel undertaken by members of a country's diaspora population returning to their country of heritage for treatment, typically driven by family and community trust networks rather than conventional destination marketing.

• Visa on arrival — A visa issued at the point of entry rather than in advance; Lebanon offers this to citizens of over 70 countries, alongside visa-free access for several Gulf states and Jordan.

• Brain drain — The emigration of skilled professionals, in this context Lebanese physicians and nurses, driven substantially by the post-2019 currency collapse and its impact on real wages.

• USEK — Holy Spirit University of Kaslik, the Lebanese institution that hosted the 2026 National Conference for the Development of the Lebanese Medical Tourism Strategy.

Frequently Asked Questions About Medical Tourism in Lebanon

Is medical tourism in Lebanon currently growing or declining? There is no current, credible market-size figure to answer this precisely. The most-cited historical figure (roughly 5,000 medical tourists in 2018) predates Lebanon's currency collapse, the 2020 port explosion, and the 2024 conflict, and no comparably sourced updated figure exists — though a 2026 national strategy initiative signals active efforts to rebuild and formalize the sector.

Is Lebanon safe for medical tourism right now? This requires current verification rather than a static answer. Lebanon's healthcare system sustained direct conflict damage between September and November 2024, and any agency or patient should check current government travel advisories and security conditions before planning treatment travel, rather than relying on this guide or any single source as a final safety assessment.

What is Lebanon known for in medical tourism specifically? Cardiology, oncology, fertility treatment (particularly IVF and egg freezing), and cosmetic and plastic surgery are the most consistently cited areas of genuine clinical strength, anchored primarily by the American University of Beirut Medical Center and a small number of other major private Beirut hospitals.

Why is the Lebanese diaspora so central to this market? The Lebanese diaspora is estimated to be several times larger than Lebanon's resident population, with deep, ongoing family ties to the country, and diaspora medical travel operates on inherited trust through family and community networks rather than the cold-outreach patient acquisition that defines marketing strategy in most other destination markets.

Do I need a visa to receive medical treatment in Lebanon? It depends on nationality. Citizens of Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the UAE can enter visa-free; Jordanian citizens receive a free visa on arrival; citizens of over 70 other countries, including the US, UK, and Canada, can typically obtain a visa on arrival; and citizens of some other countries must apply in advance or meet additional conditions.

Can Israeli passport holders enter Lebanon for medical treatment? No. Entry is refused to holders of an Israeli passport, or to any traveller with an Israeli stamp or visa in their passport, regardless of the purpose of travel.

Is Lebanese private healthcare priced in US dollars or Lebanese pounds? Private healthcare is typically priced and paid in US dollars, reflecting the collapse of the Lebanese pound since 2019 and the sector's practical need to transact in a stable currency for both domestic and international patients.

Does Lebanon have a national body or accreditation system for medical tourism like Turkey or Dubai? Not yet in a comparably developed form. Lebanon's Ministry of Public Health licenses hospitals domestically, and some hospitals hold international accreditation, but there is no dedicated national medical tourism portal or mandatory accreditation system comparable to Turkey's HealthTürkiye/TUSKA framework or Dubai's DHA/DHCC structure — a 2026 national strategy initiative is in early development to help address this gap.

What is the biggest business opportunity in Lebanon's medical tourism market right now? Diaspora-specific facilitation and concierge services represent the clearest, most structurally distinctive opportunity in this market, alongside independent provider verification services addressing the current absence of centralized national accreditation infrastructure.

How does Lebanon compare to Turkey or Dubai as a medical tourism destination? Lebanon offers a comparable dollarized cost advantage and genuine clinical strength in specific specialties, but lacks the mature national promotion infrastructure, verification systems, and reliable current market data available in both Turkey and Dubai, and carries meaningfully higher current system-stability and security considerations that require active, ongoing monitoring rather than a one-time assessment.

Can a patient realistically combine treatment in Lebanon with a broader regional trip, similar to Turkey's tourism-integrated packages? Yes, in principle, and industry sources note Lebanon's coastal and mountain landscape as a distinctive recovery setting, particularly for cosmetic surgery patients. In practice, given the security and system-stability considerations documented throughout this guide, agencies should structure any such combined itinerary conservatively and with current advisory information factored into the planning, rather than assuming the same freedom of movement and infrastructure reliability documented in this series' Turkey and Dubai guides.

Is Lebanon's medical tourism sector recovering or still declining? The available evidence supports neither a simple "recovering" nor "declining" characterization. Lebanon's major private hospitals have continued operating throughout the crisis period, and a 2026 national strategy initiative signals renewed institutional attention to the sector, but the underlying currency, brain-drain, and security pressures documented throughout this guide remain substantially unresolved as of publication — the honest characterization is a market under sustained strain with genuine, resilient institutional strength at its core, rather than a market on a clear trajectory in either direction.

What should an agency tell a prospective patient who asks whether Lebanon is a good choice compared to Turkey? This depends heavily on the individual patient's specific circumstances and risk tolerance. A diaspora patient with family in Lebanon, strong existing trust in a specific physician, and flexibility around timing may reasonably find Lebanon a good fit despite the system-level considerations documented in this guide; a patient with no prior connection to Lebanon, seeking the most predictable and best-verified possible experience, may be better served by Turkey or Dubai's more mature verification and promotion infrastructure. A responsible agency presents this comparison honestly rather than defaulting to whichever destination it has a commercial relationship with.

Conclusion: Approaching Medical Tourism in Lebanon Responsibly

Medical tourism in Lebanon is, in 2026, a market defined by a genuine tension between real, internationally recognized clinical strength and an unresolved, multi-year national crisis — and any agency, investor, or hospital IPD evaluating this market needs to hold both facts honestly rather than defaulting to either uncritical optimism or blanket avoidance.

Action items for agencies and IPDs:

1. Do not cite the outdated 2018 patient-volume figure as a current market-size estimate — be explicit with stakeholders that no reliable current figure exists, and build demand estimates from provider-level and diaspora-population data instead.

2. Build diaspora medical travel into your core strategy from the outset rather than treating it as a secondary segment — it is structurally the most distinctive and durable demand driver this market offers.

3. Treat current security and travel-advisory monitoring as an ongoing operational practice, not a one-time due-diligence step, given the documented volatility of Lebanon's recent security situation.

4. Independently verify MOPH licensing and any claimed international accreditation for every partner provider, given the current absence of a centralized national verification portal comparable to Turkey's or Dubai's.

5. Communicate Lebanon's genuine two-sided reality honestly in all patient-facing content — real clinical strength inside a strained system — rather than producing purely promotional content that omits material context a prospective patient would reasonably want to know.

6. Consider engaging directly with the emerging USEK-led national medical tourism strategy process, given how early-stage and genuinely open to outside input this initiative currently appears to be relative to the more established frameworks elsewhere in this guide series.

The throughline across all six markets covered in this series so far — Australia, Germany, the United Kingdom, Dubai, Turkey, and now Lebanon — is that a genuinely useful medical tourism market guide has to describe the market as it actually is, not as a generic template would predict. Five of those six markets rewarded a fairly conventional growth-and-opportunity framing, adjusted for each country's specific regulatory and structural quirks. Lebanon does not. It is the first market in this series where the single most valuable thing this guide can offer an agency, investor, or hospital IPD is not a growth projection, but an honest, well-sourced account of a market where genuine clinical excellence and genuine national crisis coexist — and where the businesses most likely to succeed will be the ones built with that duality in mind from day one, rather than around either half of the story alone.

For more on adjacent destination markets, see our guides to medical tourism in Abu Dhabi and medical tourism in Mexico, and for a primer on the facilitator role itself, see what medical tourism facilitators do.

Footnotes and Sources

1. Bou Sanayeh E, El Chamieh C. "The fragile healthcare system in Lebanon: sounding the alarm about its possible collapse." Health Economics Review, 2023.

2. "Navigating turbulence: analyzing the resilience of Lebanon's healthcare system in a multi-crisis scenario." Health Research Policy and Systems, 2025.

3. "Exodus of Lebanese doctors in times of crisis: a qualitative study." Frontiers in Health Services, 2023.

4. "The Factors Driving Lebanon's Medical Brain Drain." Middle East Policy, 2025.

5. ReliefWeb — Lebanon's deep healthcare crisis exposed through communicable diseases

6. DevelopmentAid — Lebanon's healthcare system struggles to cope amid conflict and economic collapse

7. Gulf News — Doctors, nurses in crisis-hit Lebanon go on 2-day strike

8. eTurboNews — Lebanon Emerges as a Leading Medical Tourism Destination in the Middle East

9. Global Healthcare Accreditation — Medical Tourism Statistics and Facts

10. Market Data Forecast — Middle East and Africa Medical Tourism Market Size Report, 2034

11. Better by MTA — Medical Tourism Destination: Lebanon

12. New Holidays — Best Clinics Lebanon: 10 Reasons Why Lebanon Is the Next Medical & Dental Tourism Hub

13. Best Cardiac Hospitals — Top 20 Best Hospitals in Lebanon for Medical Tourism

14. Waradana — Top 10 Hospitals in Lebanon for Medical Tourism

15. AUBMC — Division of Reproductive Endocrinology & Infertility

16. AUBMC — Fertility Preservation Program

17. VisaGuide.World — Lebanon Visa: Ways to Apply and Visa Requirements

18. Pegasus Airlines — Lebanon Visa Application, Visa Requirements and Fees (2026)

19. YEN.com.gh — Lebanon Releases List of Countries Whose Citizens Qualify for Visa on Arrival in 2026

20. Things To Do In Lebanon — Visas and Entry Requirements

21. iExplore — Lebanon Visas and Vaccinations

This guide addresses an active, evolving humanitarian, economic, and security situation, and the information here reflects publicly available sources as of publication. Agencies, patients, and investors should independently verify current conditions — including official government travel advisories, current Ministry of Public Health guidance, and individual hospital operating status — before making any travel, business, or investment decision related to Lebanon. Directional figures on market size and patient volumes should be treated with particular caution given the acknowledged absence of any current, audited national estimate; do not rely on the pre-crisis 2018 figure cited in this guide as a current benchmark. This article was produced for informational and market-intelligence purposes and does not constitute medical, legal, immigration, financial, or security travel advice, and should not be relied upon as a substitute for independent professional advice or official government guidance specific to an individual's circumstances. Given how quickly conditions in Lebanon have changed over the period this guide documents, readers should treat any specific operational detail — visa processing times, named specialist availability, or a given hospital's current accreditation status — as a starting point for direct verification rather than a settled fact.